Evidence map›Paper›PMID 42198531›Full record

ArticleToxics2026

Assessment of Paraquat Resistance and Degradation Potential in

Manuel Isaac Morales-Olivares, María Luisa Castrejón-Godínez, Patricia Mussali-Galante, Efraín Tovar-Sánchez, Alexis Rodríguez

Abstract read
In one paragraph

Article in Toxics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Manuel Isaac Morales-OlivaresPrograma de Doctorado en Ciencias Naturales, Universidad Autónoma del Estado de Morelos, Av. Universidad 1001, Col. Chamilpa, Cuernavaca C.P. 62209, Morelos, Mexico.
María Luisa Castrejón-GodínezFacultad de Ciencias Biológicas, Universidad Autónoma del Estado de Morelos, Av. Universidad 1001, Col. Chamilpa, Cuernavaca C.P. 62209, Morelos, Mexico.ORCID 0000-0001-7212-3868
Patricia Mussali-GalanteCentro de Investigación en Biotecnología, Universidad Autónoma del Estado de Morelos, Av. Universidad 1001, Col. Chamilpa, Cuernavaca C.P. 62209, Morelos, Mexico.ORCID 0000-0002-6405-058X
Efraín Tovar-SánchezCentro de Investigación en Biodiversidad y Conservación, Universidad Autónoma del Estado de Morelos, Av. Universidad 1001, Col. Chamilpa, Cuernavaca C.P. 62209, Morelos, Mexico.ORCID 0000-0001-7152-7924
Alexis RodríguezCentro de Investigación en Biotecnología, Universidad Autónoma del Estado de Morelos, Av. Universidad 1001, Col. Chamilpa, Cuernavaca C.P. 62209, Morelos, Mexico.ORCID 0000-0002-1503-5156

Funding

Secretaría de Ciencia, Humanidades, Tecnología e Innovación (SECIHTI) CBF2023-2024-2134
6 · The paper itself

Abstract

Paraquat is an herbicide widely used to control weeds in various crops. Due to its use in large quantities, its dispersal into the environment is frequent, leading to contamination and negative health effects on non-target organisms because of its high toxicity and persistence in soils. Therefore, it is necessary to develop sustainable strategies to remediate sites contaminated by this compound. Bacterial remediation is a promising alternative for removing paraquat from the environment; however, the metabolic pathways used by bacteria for its degradation have not yet been precisely described. In this context, it is essential to characterize bacterial species capable of resisting and degrading paraquat, as well as to elucidate the molecular mechanisms involved in these processes. The objective of this work was to evaluate the paraquat resistance and degradation potential of the bacterial strain

Indexed as

bacterial resistancebiodegradationbioremediationenvironmental pollutionherbicidepesticides

Identifiers

PMID42198531
PMCPMC13210998

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.